Efficacy of Aurosling in Frontalis Sling Suspension Surgery
NCT ID: NCT00753831
Last Updated: 2012-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
16 participants
INTERVENTIONAL
2009-01-31
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Aurosling
Aurosling
Silicon rod to be used in frontalis suspension surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aurosling
Silicon rod to be used in frontalis suspension surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Severe Ptosis (MRD\<0)
* Poor levator function (\<4mm by Berke's method)
* Myogenic Ptosis (Myasthenia gravis)
* Chronic progressive external ophthalmoplegia
* Neurogenic Ptosis (Third cranial palsy)
* Blepharospasm
* Ptosis caused by trauma
Exclusion Criteria
* Horners syndrome
* Blepharochalasis/Dermatochalasis
* Mechanical Ptosis
* Mild or Moderate Ptosis (MRD 1\>1)
* Good or fair levator function (\>4 mm by Berke's method)
* Previous Ptosis surgery
* Ptosis associated syndromes/Other anomalies including
* Marcus Gunn jaw winking syndrome
* Blepharophimosis syndrome
* Dry eye syndromes
* Corneal anesthesia
* Medical/Pediatric/Anesthesia condition contraindicating to surgery or anesthesia
* Nystagmus where adequate measurements could not be done
* Uncorrected vertical squint of any sort
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aurolab
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Usha Kim, DO, Dip NB
Role: PRINCIPAL_INVESTIGATOR
Aravind Eye Hospital, Madurai
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aravind Eye Hospital
Madurai, Tamil Nadu, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2PR1220827
Identifier Type: -
Identifier Source: org_study_id